RecruitingPhase 3NCT06669013

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas

Studying Alveolar rhabdomyosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
N.N. Petrov National Medical Research Center of Oncology
Principal Investigator
Svetlana Kulyova, MD, Phd
Head of Children's Oncology Department
Intervention
dinutuximab beta(drug)
Enrollment
40 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06669013 on ClinicalTrials.gov

Other trials for Alveolar rhabdomyosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Alveolar rhabdomyosarcoma →

← Back to all trials